Filter

Refine by collections

  • Thyroid (1)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 1 of 1 items for :

  • "SARS-CoV-2" x
Clear All
Simona Censi Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Simona Censi in
Google Scholar
PubMed Close
,
Laura Salmaso Clinical Governance Unit, Azienda Zero, Veneto Region, Italy

Search for other papers by Laura Salmaso in
Google Scholar
PubMed Close
,
Filippo Ceccato Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Filippo Ceccato in
Google Scholar
PubMed Close
,
Jacopo Manso Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy
Pediatric Endocrinology Unit, Department of Women's and Children's Health, Padua University Hospital, Padova, Italy

Search for other papers by Jacopo Manso in
Google Scholar
PubMed Close
,
Ugo Fedeli Clinical Governance Unit, Azienda Zero, Veneto Region, Italy

Search for other papers by Ugo Fedeli in
Google Scholar
PubMed Close
,
Mario Saia Clinical Governance Unit, Azienda Zero, Veneto Region, Italy

Search for other papers by Mario Saia in
Google Scholar
PubMed Close
, and
Caterina Mian Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Caterina Mian in
Google Scholar
PubMed Close

analyzed so far. Another event claimed to impact GD incidence is thought to be the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Certainly, following the widespread use of SARS-CoV-2 vaccines, many cases of thyroid dysfunction

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0292
Volume/Issue:
Volume 12: Issue 12
Open access